Efficacy of endoscopic screening for esophageal cancer in China (ESECC): Design and preliminary results of a population-based randomised controlled trial

Gut

Volumn 68, Issue 2, 2019, Pages 198-206

  He, Zhonghu ^a   Liu, Zhen ^a   Liu, Mengfei ^a   Guo, Chuanhai ^a   Xu, Ruiping ^b   Li, Fenglei ^c   Liu, Anxiang ^b   Yang, Haijun ^b   Shen, Lin ^a   Wu, Qi ^a   Duan, Liping ^d   Li, Xiang ^a   Zhang, Chaoting ^a   Pan, Yaqi ^a   Cai, Hong ^a   Ke, Yang ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b Anyang Cancer Hospital   (China)

^c Hua County People's Hospital   (China)

^d PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

China; efficacy; esophageal squamous cell carcinoma; population based screening; randomized control trial

Indexed keywords

ADULT; ADVANCED CANCER; ALL CAUSE MORTALITY; ARTICLE; BODY MASS; CANCER GRADING; CANCER SCREENING; CANCER STAGING; CHINA; CHROMOENDOSCOPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ENDOSCOPY; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; AGED; EARLY CANCER DIAGNOSIS; ESOPHAGOSCOPY; ESOPHAGUS TUMOR; MASS SCREENING; PROCEDURES; RURAL POPULATION; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; CHINA; EARLY DETECTION OF CANCER; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FEMALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; RISK FACTORS; RURAL POPULATION;

EID: 85049216179     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2017-315520     Document Type: Article

References (30)

1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.
2. Tran GD, Sun XD, Abnet CC, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 2005;113:456-63.
3. Wei WQ, Abnet CC, Lu N, et al. Risk factors for oesophageal squamous dysplasia in adult inhabitants of a high risk region of China. Gut 2005;54:759-63.
4. Guo W, Blot WJ, Li JY, et al. A nested case-control study of oesophageal and stomach cancers in the Linxian nutrition intervention trial. Int J Epidemiol 1994;23:444-50.
5. Wu M, Zhao JK, Zhang ZF, et al. Smoking and alcohol drinking increased the risk of esophageal cancer among Chinese men but not women in a high-risk population. Cancer Causes Control 2011;22:649-57.
6. Roth MJ, Strickland KL, Wang GQ, et al. High levels of carcinogenic polycyclic aromatic hydrocarbons present within food from Linxian, China may contribute to that region's high incidence of oesophageal cancer. Eur J Cancer 1998;34:757-8.
7. Lu SH, Ohshima H, Fu HM, et al. Urinary excretion of N-nitrosamino acids and nitrate by inhabitants of high- and low-risk areas for esophageal cancer in Northern China: endogenous formation of nitrosoproline and its inhibition by vitamin C. Cancer Res 1986;46:1485-91.
8. Guo F, Liu Y, Wang X, et al. Human papillomavirus infection and esophageal squamous cell carcinoma: a case-control study. Cancer Epidemiol Biomarkers Prev 2012;21:780-5.
9. He Z, Xu Z, Hang D, et al. Anti-HPV-E7 seropositivity and risk of esophageal squamous cell carcinoma in a high-risk population in China. Carcinogenesis 2014;35:816-21.
10. Zeng H, Zheng R, Guo Y, et al. Cancer survival in China, 2003-2005: a populationbased study. Int J Cancer 2015;136:1921-30.
11. Wang GQ, Jiao GG, Chang FB, et al. Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening. Ann Thorac Surg 2004;77:1740-4.
12. Yang S, Wu S, Huang Y, et al. Screening for oesophageal cancer. Cochrane Database Syst Rev 2012;12:CD007883.
13. Wang GQ, Abnet CC, Shen Q, et al. Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut 2005;54:187-92.
14. Mannath J, Ragunath K. Role of endoscopy in early oesophageal cancer. Nat Rev Gastroenterol Hepatol 2016;13:720-30.
15. Dawsey SM, Fleischer DE, Wang GQ, et al. Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer 1998;83:220-31.
16. C hen Q, Yu L, Hao C, et al. Effectiveness evaluation of organized screening for esophageal cancer: a case-control study in Linzhou city, China. Sci Rep 2016;6:35707.
17. Wei WQ, Chen ZF, He YT, et al. Long-Term Follow-Up of a Community Assignment, One-Time Endoscopic Screening Study of Esophageal Cancer in China. J Clin Oncol 2015;33:1951-7.
18. Ro TH, Mathew MA, Misra S. Value of screening endoscopy in evaluation of esophageal, gastric and colon cancers. World J Gastroenterol 2015;21:9693-706.
19. Lao-Sirieix P, Fitzgerald RC. Screening for oesophageal cancer. Nat Rev Clin Oncol 2012;9:278-87.
20. Ke L. Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970-90. Int J Cancer 2002;102:271-4.
21. Liu F, Guo F, Zhou Y, et al. The Anyang Esophageal Cancer Cohort Study: study design, implementation of fieldwork, and use of computer-aided survey system. PLoS One 2012;7:e31602.
22. Brooks R. EuroQol: the current state of play. Health Policy 1996;37:53-72.
23. He Z, Zhao Y, Guo C, et al. Prevalence and risk factors for esophageal squamous cell cancer and precursor lesions in Anyang, China: a population-based endoscopic survey. Br J Cancer 2010;103:1085-8.
24. Li X, Cai H, Wang C, et al. Economic burden of gastrointestinal cancer under the protection of the New Rural Cooperative Medical Scheme in a region of rural China with high incidence of oesophageal cancer: cross-sectional survey. Trop Med Int Health 2016;21:907-16.
25. PDQ® Screening and Prevention Editorial Board. PDQ Esophageal Cancer Screening. 17. Bethesda, MD: National Cancer Institute, 2017. https://www. cancer. gov/ types/ esophageal/ hp/ esophageal- screening- pdq
26. Gerson LB, Triadafilopoulos G. Screening for esophageal adenocarcinoma: an evidence-based approach. Am J Med 2002;113:499-505.
27. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016;66:115-32.
28. Liu M, Liu Z, Cai H, et al. A model to identify individuals at high risk for esophageal squamous cell carcinoma and precancerous lesions in regions of high prevalence in China. Clin Gastroenterol Hepatol 2017;15:1538-46.
29. Rice TW, Ishwaran H, Hofstetter WL, et al. Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus 2016;29:897-905.
30. Rice TW, Ishwaran H, Blackstone EH, et al. Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus 2016;29:913-9.